Skip to main content

FOR US HEALTHCARE PROFESSIONALS ONLY

TYVASO and TYVASO DPI are approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.

CONTACT US

For more information about TYVASO, please use the contact information below:

Questions about TYVASO or United Therapeutics?

Call 1-877-UNITHER (1-877-864-8437).

Receive updates and information from the TYVASO Support Program.